One of the best ways to diagnose breast cancer early, aid in treatment decisions, or predict treatment response is to use cancer biomarkers.

HER2-positive early breast cancer molecular biomarkers are a key research area for Associate Professor Aleix Prat.

He explains that investigating HER2-positive early breast cancer is important as it can become an aggressive disease if left untreated. Find out more in this episode.